Form 4: DarioHealth Corp. Director Adam Stern Reports Changes in Beneficial Ownership

Director Adam Stern reports changes in beneficial ownership of DarioHealth Corp. securities, including common stock and preferred stock, following a transaction on January 7, 2025.

Summary

• On January 10, 2025, Adam Stern, a director of DarioHealth Corp., filed a Form 4 with the SEC reporting changes in his beneficial ownership of the company's securities.
• The reported transaction occurred on January 7, 2025.
• Stern directly owns 194,341 shares of common stock.
• He indirectly owns 122,909 shares of common stock and 123,763 shares of Series-C Preferred Stock through AKS Family Partners L.P.
• Stern also reported the acquisition of Series D-2 Preferred Stock, convertible into common stock at $0.83 per share, subject to shareholder approval and a 19.99% ownership blocker.
• The Series D-2 Preferred Stock entitles holders to dividends of 10% of the common stock issuable upon conversion for each full quarter of holding, totaling four quarters from the closing date.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Future Outlook

The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, on the 12-month anniversary of the issuance date.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their holdings and transactions in the company's securities.

Stakeholder Impact

• Shareholders are informed about changes in the beneficial ownership of a director, providing insights into insider activity.

Key Dates